BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36889013)

  • 1. Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood.
    Ravn K; Hatt L; Singh R; Schelde P; Hansen ES; Vogel I; Uldbjerg N; Niemann I; Sunde L
    Placenta; 2023 Apr; 135():7-15. PubMed ID: 36889013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
    Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of gestational trophoblastic disease.
    Fisher RA; Maher GJ
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of STR genotyping diagnosis for hydatidiform mole and nonmolar gestation].
    Zheng XZ; Qin XY; Wang P; Xu F; Ma JH; Wang XL; Chen SW; Feng WQ; Zhu L; Yin CH; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):609-615. PubMed ID: 30107666
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
    Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN
    Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
    Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
    Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood.
    Sunde L; Singh R; Ravn K; Schelde P; Hansen ES; Uldbjerg N; Niemann I; Hatt L
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1565. PubMed ID: 33306861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaics and moles.
    Sunde L; Niemann I; Hansen ES; Hindkjaer J; Degn B; Jensen UB; Bolund L
    Eur J Hum Genet; 2011 Oct; 19(10):1026-31. PubMed ID: 21654731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgenetic/biparental mosaicism in a diploid mole-like conceptus: report of a case with triple paternal contribution.
    Donzel M; Gaillot-Durand L; Joubert M; Aziza J; Beneteau C; Mauduit C; Ploteau S; Hajri T; Bolze PA; Massardier J; Devouassoux-Shisheboran M; Sunde L; Allias F
    Virchows Arch; 2023 Nov; 483(5):709-715. PubMed ID: 37695410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of p57 immunohistochemistry and DNA ploidy analysis by fluorescence in situ hybridisation in hydatidiform moles.
    Wong YP; Chia WK; Selimin A; Chia PY; Mustangin M; Shuib S; Khong TY; Tan GC
    Malays J Pathol; 2021 Dec; 43(3):341-351. PubMed ID: 34958055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study.
    Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M
    Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Parental Contribution to Molar Genome Leads to Diagnosis of Recurrent Hydatidiform Mole in a Family with
    Wang RY; Li YJ; Zhen L; Jiang F; Gu CM; Li DZ
    Fetal Pediatr Pathol; 2022 Jun; 41(3):511-515. PubMed ID: 33252287
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies.
    Koc S; Ozdegirmenci O; Tulunay G; Ozgul N; Kose MF; Bulbul D
    Int J Gynecol Cancer; 2006; 16(2):940-3. PubMed ID: 16681793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis.
    Jeffers MD; O'Dwyer P; Curran B; Leader M; Gillan JE
    Int J Gynecol Pathol; 1993 Oct; 12(4):315-23. PubMed ID: 8253548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
    Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
    J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
    Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
    Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auxiliary and experimental diagnostic techniques for hydatidiform moles.
    Usui H
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3077-3086. PubMed ID: 36098274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis.
    Ronnett BM
    Arch Pathol Lab Med; 2018 Dec; 142(12):1485-1502. PubMed ID: 30500280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.